Serum IgG4 and IgG for the diagnosis of autoimmune pancreatitis: A systematic review with meta-analysis

Clinics and Research in Hepatology and Gastroenterology

Volumn 40, Issue 1, 2016, Pages 99-109

  Lian, Ming Jian ^a   Liu, Shuang ^a   Wu, Guang Ye ^a   Liu, Shu Ye ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Third Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4;

ARTICLE; AUTOIMMUNE PANCREATITIS; BIBLIOGRAPHIC DATABASE; CHECKLIST; CHINESE BIOMEDICAL DATABASE; CHRONIC PANCREATITIS; CNKI DATABASE; COCHRANE LIBRARY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EMBASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MEDLINE; META ANALYSIS; PANCREAS CANCER; QUALITY ASSESSMENT OF DIAGNOSTIC ACCURACY STUDIES CHECKLIST; QUALITY CONTROL PROCEDURES; SCIENCEDIRECT; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VIP DATABASE; WANFANG DATABASE; WEB OF SCIENCE; AUTOIMMUNE DISEASES; BLOOD; IMMUNOLOGY; PANCREATITIS, CHRONIC;

AUTOIMMUNE DISEASES; HUMANS; IMMUNOGLOBULIN G; PANCREATITIS, CHRONIC;

EID: 84959491492     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2015.06.002     Document Type: Article

References (32)

1. Yoshida K., Toki F., Takeuchi T., Watanabe S., Shiratori K., Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995, 40(7):1561-1568.
2. Erdogan D., Kloek J.J., ten Kate F.J., Rauws E.A., Busch O.R., Gouma D.J., et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg 2008, 95(6):727-734.
3. van Heerde M.J., Biermann K., Zondervan P.E., Kazemier G., van Eijck C.H., Pek C., et al. Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head. Dig Dis Sci 2012, 57(9):2458-2465.
4. Choi E.K., Kim M.H., Lee T.Y., Kwon S., Oh H.C., Hwang C.Y., et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007, 35(2):156-161.
5. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., et al. High Serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344(10):732-738.
6. Sarles H., Sarles J.C., Muratore R., Guien C. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease?. Am J Dig Dis 1961, 6:688-698.
7. Okazaki K., Uchida K., Ohana M., Nakase H., Uose S., Inai M., et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000, 118(3):573-581.
8. Song T.J., Kim M.H., Moon S.H., Eum J.B., Park do H., Lee S.S., et al. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone. Am J Gastroenterol 2010, 105(7):1655-1660.
9. Ghazale A., Chari S.T., Smyrk T.C., Levy M.J., Topazian M.D., Takahashi N., et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007, 102(8):1646-1653.
10. Talar-Wojnarowska R., Gasiorowska A., Olakowski M., Dranka-Bojarowska D., Lampe P., Śmigielski J., et al. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis. Adv Med Sci 2014, 59(2):288-292.
11. van Heerde M.J., Buijs J., Hansen B.E., de Waart M., van Eijck C.H., Kazemier G., et al. Serum level of ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma. Dig Dis Sci 2014, 59(6):1322-1329.
12. Sadler R., Chapman R.W., Simpson D., Soonawalla Z.F., Waldegrave E.L., Burden J.M., et al. The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study. Eur J Gastroenterol Hepatol 2011, 23(2):139-145.
13. Naitoh I., Nakazawa T., Hayashi K., Okumura F., Miyabe K., Shimizu S., et al. Clinical differences between mass-forming autoimmune pancreatitis and pancreatic cancer. Scand J Gastroenterol 2012, 47(5):607-613.
14. Whiting P.F., Rutjes A.W., Westwood M.E., Mallett S., Deeks J.J., Reitsma J.B., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155(8):529.
15. Walter S.D. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002, 21(9):1237-1256.
16. Moses LE1, Shapiro D., Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993, 12(14):1293-1316.
17. Zamora J1, Abraira V., Muriel A., Khan K., Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31.
18. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
19. Dinnes J., Deeks J., Kirby J., Roderick P. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess 2005, 9(12):1-113.
20. Deeks J.J., Macaskill P., Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005, 58(9):882-893.
21. Chang M.C., Liang P.C., Jan S., Yang C.Y., Tien Y.W., Wei S.C., et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Pancreatology 2014, 14(5):366-372.
22. Hirano K., Kawabe T., Yamamoto N., Nakai Y., Sasahira N., Tsujino T., et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta 2006, 367(1):181-184.
23. Kaji R., Takedatsu H., Okabe Y., Ishida Y., Sugiyama G., Yonemoto K., Mitsuyama K., et al. Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients. J Gastroenterol Hepatol 2012, 27(2):268-272.
24. Lu Q., He Z., Zhang L., Shen Q., Tang G. Significance on the combination determination of serum IgG4 and CA199 in differential diagnosis between autoimmune pancreatitis and pancreatic cancer. Lab Med 2011, 26(11):746-749.
25. Sánchez-Casta Ón M., de Las Heras-Casta O.G., Gómez C., López-Hoyos M. Differentiation of autoimmune pancreatitis from pancreas cancer: utility of anti-amylase and anti-carbonic anhydrase II autoantibodies. Autoimmun Highlights 2012, 3(1):11-20.
26. Tabata T., Kamisawa T., Takuma K., Anjiki H., Egawa N., Kurata M., et al. Serum IgG4 concentrations and IgG4-related sclerosing disease. Clini Chim Acta 2009, 408(1):25-28.
27. van Toorenenbergen A.W., van Heerde M.J., van Buuren H.R. Potential value of serum total IgE for differentiation between autoimmune pancreatitis and pancreatic cancer. Scand J Immunol 2010, 72(5):444-448.
28. Wu W.C., Yao X.Z., Jin D.Y., Wang D.S., Lou W.H., Qin X.Y. Clinical strategies for differentiating autoimmune pancreatitis from pancreatic malignancy to avoid unnecessary surgical resection. J Dig Dis 2013, 14(9):500-508.
29. Kanno A., Masamune A., Okazaki K., Kamisawa T., Kawa S., Nishimori I., et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas 2015, 44(4):535-539.
30. Matsubayashi H., Kakushima N., Takizawa K., Tanaka M., Imai K., Hotta K., et al. Diagnosis of autoimmune pancreatitis. World J Gastroenterol 2014, 20(44):16559.
31. Morselli-Labate A.M., Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis. J Gastroenterol Hepatol 2009, 24(1):15-36.
32. Chari S.T., Kloeppel G., Zhang L., Notohara K., Lerch M.M., Shimosegawa T., et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 2010, 39:549-554.